Design and synthesis of binding growth factors

International Journal of Molecular Sciences

Volumn 13, Issue 5, 2012, Pages 6053-6072

  Tada, Seiichi ^a   Kitajima, Takashi ^a   Ito, Yoshihiro ^a  

^a RIKEN   (Japan)

Author keywords

Collagen; Growth factor; Immobilization; Peptide ligation; Protein engineering; Tissue engineering

Indexed keywords

COLLAGEN; FIBRIN; GROWTH FACTOR; ORGANIC COMPOUND; TITANIUM; BIOMATERIAL; PEPTIDE; PROTEIN BINDING; SIGNAL PEPTIDE;

BINDING AFFINITY; BONE REGENERATION; CELL ADHESION; CONJUGATION; DNA SEQUENCE; DOWN REGULATION; GENE FUSION; HUMAN; INTERNALIZATION; NERVE REGENERATION; NONHUMAN; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN CROSS LINKING; PROTEIN ENGINEERING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; TISSUE ENGINEERING; TISSUE REPAIR; WOUND HEALING; CHEMISTRY; METABOLISM; PROCEDURES;

BIOCOMPATIBLE MATERIALS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; PEPTIDES; PROTEIN BINDING; PROTEIN ENGINEERING; TISSUE ENGINEERING;

EID: 84861706178     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms13056053     Document Type: Review

References (101)

1. Werner, S.; Grose, R. Regulation of wound healing by growth factors and cytokines. Physiol. Rev. 2003, 83, 835-870.
2. Whitaker, M.J.; Quirk, R.A.; Howdle, S.M.; Shakesheff, K.M. Growth factor release from tissue engineering scaffolds. Pharm. Pharmacol. 2001, 53, 1427-1437.
3. Massagué, J.; Pandiella, A. Membrane-anchored growth factors. Ann. Rev. Biochem. 1993, 62, 515-541.
4. Iwamoto, R.; Mekada, E. Heparin-binding EGF-like growth factor: A juxtacrine growth factor. Cytokine Growth Factor Rev. 2000, 11, 335-344.
5. Kitajima, T.; Ito, Y. Artificial Binding Growth Factors. In Handbook of Intelligent Scaffolds for Tissue Engineering and Regenerative Medicine; Khang, G.; Ed.; Pan Stanford Publishing: Singapore, 2012; pp. 337-353.
6. Ito, Y. Elaborate synthesis of biological macromolecules. ChemBioChem 2012, in press.
7. Tuan, T.L.; Cheung, D.T.; Wu, L.T.; Yee, A.; Gabriel, S.; Han, B.; Morton, L.; Nimni, M.E.; Hall, F.L. Engineering, expression and renaturation of targeted TGF-beta fusion proteins. Connect. Tissue Res. 1996, 34, 1-9.
8. Andrades, J.A.; Han, B.; Becerra, J.; Sorgente, N.; Hall, F.L.; Nimni, M.E. A recombinant human TGF-beta1 fusion protein with collagen-binding domain promotes migration, growth, and differentiation of bone marrow mesenchymal cells. Exp. Cell. Res. 1999, 250, 485-498.
9. Hall, F.L.; Kaiser, A.; Liu, L.; Chen, Z.H.; Hu, J.; Nimni, M.E.; Beart, R.W., Jr.; Gordon, E.M. Design, expression, and renaturation of a lesion-targeted recombinant epidermal growth factor-von Willebrand factor fusion protein: Efficacy in an animal model of experimental colitis. Int. J. Mol. Med. 2000, 6, 635-643.
10. Andrades, J.A.; Santamaría, J.A.; Wu, L.T.; Hall, F.L.; Nimni, M.E.; Becerra, J. Production of a recombinant human basic fibroblast growth factor with a collagen binding domain. Protoplasma 2001, 218, 95-103.
11. Han, B.; Perelman, N.; Tang, B.; Hall, F.; Shors, E.C.; Nimni, M.E. Collagen-targeted BMP3 fusion proteins arrayed on collagen matrices or porous ceramics impregnated with Type I collagen enhance osteogenesis in a rat cranial defect model. J. Orthop. Res. 2002, 20, 747-755.
12. Nishi, N.; Matsushita, O.; Yuube, K.; Miyanaka, H.; Okabe, A.; Wada, F. Collagen-binding growth factors: Production and characterization of functional fusion proteins having a collagen-binding domain. Proc. Natl. Acad. Sci.USA 1998, 95, 7018-7023.
13. Brewster, L.P.; Washington, C.; Brey, E.M.; Gassman, A.; Subramanian, A.; Calceterra, J.; Wolf, W.; Hall, C.L.; Velander, W.H.; Burgess, W.H.; et al. Construction and characterization of a thrombin-resistant designer FGF-based collagen binding domain angiogen. Biomaterials 2008, 29, 327-336.
14. Lin, H.; Chen, B.; Sun, W.; Zhao, W.; Zhao, Y.; Dai, J. The effect of collagen-targeting platelet-derived growth factor on cellularization and vascularization of collagen scaffolds. Biomaterials 2006, 27, 5708-5714.
15. Zhao, W.; Chen, B.; Li, X.; Lin, H.; Sun, W.; Zhao, Y.; Wang, B.; Zhao, Y.; Han, Q.; Dai, J. Vascularization and cellularization of collagen scaffolds incorporated with two different collagen-targeting human basic fibroblast growth factors. J. Biomed. Mater. Res. A 2007, 82, 630-636.
16. Chen, B.; Lin, H.; Zhao, Y.; Wang, B.; Zhao, Y.; Liu, Y.; Liu, Z.; Dai, J. Activation of demineralized bone matrix by genetically engineered human bone morphogenetic protein-2 with a collagen binding domain derived from von Willebrand factor propolypeptide. J. Biomed. Mater. Res. A 2007, 80, 428-434.
17. Sun, W.; Lin, H.; Chen, B.; Zhao, W.; Zhao, Y.; Dai, J. Promotion of peripheral nerve growth by collagen scaffolds loaded with collagen-targeting human nerve growth factor-beta. J. Biomed. Mater. Res. A 2007, 83, 1054-1061.
18. Han, Q.; Sun, W.; Lin, H.; Zhao, W.; Gao, Y.; Zhao, Y.; Chen, B.; Xiao, Z.; Hu, W.; Li, Y.; Yang, B.; Dai, J. Linear ordered collagen scaffolds loaded with collagen-binding brain-derived neurotrophic factor improve the recovery of spinal cord injury in rats. Tissue Eng. Part A 2009, 15, 2927-2935.
19. Yang, Y.; Zhao, Y.; Chen, B.; Han, Q.; Sun, W.; Xiao, Z.; Dai, J. Collagen-binding human epidermal growth factor promotes cellularization of collagen scaffolds. Tissue Eng. Part A 2009, 15, 3589-3596.
20. Zhang, J.; Ding, L.; Zhao, Y.; Sun, W.; Chen, B.; Lin, H.; Wang, X.; Zhang, L.; Xu, B.; Dai, J. Collagen-targeting vascular endothelial growth factor improves cardiac performance after myocardial infarction. Circulation 2009, 119, 1776-1784.
21. Fan, J.; Xiao, Z.; Zhang, H.; Chen, B.; Tang, G.; Hou, X.; Ding, W.; Wang, B.; Zhang, P.; Dai, J.; Xu, R. Linear ordered collagen scaffolds loaded with collagen-binding neurotrophin-3 promote axonal regeneration and partial functional recovery after complete spinal cord transection. J. Neurotrauma 2010, 27, 1671-1683.
22. Ishikawa, T.; Terai, H.; Kitajima, T. Production of a biologically active epidermal growth factor fusion protein with high collagen affinity. J. Biochem. 2001, 129, 627-633.
23. Kitajima, T.; Terai, H.; Ito, Y. A fusion protein of hepatocyte growth factor for immobilization to collagen. Biomaterials 2007, 28, 1989-1997.
24. Ishikawa, T.; Eguchi, M.; Wada, M.; Iwami, Y.; Tono, K.; Iwaguro, H.; Masuda, H.; Tamaki, T.; Asahara, T. Establishment of a functionally active collagen-binding vascular endothelial growth factor fusion protein in situ. Arterioscler. Thromb. Vasc. Biol. 2006, 26, 1998-2004.
25. Sakiyama-Elbert, S.E.; Panitch, A.; Hubbell, J.A. Development of growth factor fusion proteins for cell-triggered drug delivery. FASEB J. 2001, 15, 1300-1302.
26. Schmoekel, H.G.; Weber, F.E.; Schense, J.C.; Grätz, K.W.; Schawalder, P.; Hubbell, J.A. Bone repair with a form of BMP-2 engineered for incorporation into fibrin cell ingrowth matrices. Biotechnol. Bioeng. 2005, 89, 253-262.
27. Geer, D.J.; Swartz, D.D.; Andreadis, S.T. Biomimetic delivery of keratinocyte growth factor upon cellular demand for accelerated wound healing in vitro and in vivo. Am. J. Pathol. 2005, 167, 1575-1586.
28. Zisch, A.H.; Schenk, U.; Schense, J.C.; Sakiyama-Elbert, S.E.; Hubbell, J.A. Covalently conjugated VEGF-fibrin matrices for endothelialization. J. Control. Release 2001, 72, 101-113.
29. 121 from fibrin implants induces local and controlled blood vessel growth. Circ. Res. 2004, 94, 1124-1132.
30. Sahni, A.; Francis, C.W. Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation. Blood 2000, 96, 3772-3778.
31. Ehrbar, M.; Zeisberger, S.M.; Raeber, G.P.; Hubbell, J.A.; Schnell, C.; Zisch, A.H. The role of actively released fibrin-conjugated VEGF for VEGF receptor 2 gene activation and the enhancement of angiogenesis. Biomaterials 2008, 29, 1720-1729.
32. Lorentz, K.M.; Yang, L.; Frey, P.; Hubbell, J.A. Engineered insulin-like growth factor-1 for improved smooth muscle regeneration. Biomaterials 2012, 33, 494-503.
33. Kitajima, T.; Sakuragi, M.; Hasuda, H.; Ozu, T.; Ito, Y. A chimeric epidermal growth factor with fibrin affinity promotes repair of injured keratinocyte sheets. Acta Biomater. 2009, 5, 2623-2632.
34. Kawase, Y.; Ohdate, Y.; Shimojo, T.; Taguchi, Y.; Kimizuka, F.; Kato, I. Construction and characterization of a fusion protein with epidermal growth factor and the cell-binding domain of fibronectin. FEBS Lett. 1992, 298, 126-128; erratum in FEBS Lett. 1992, 301, 124.
35. Hashi, H.; Hatai, M.; Kimizuka, F.; Kato, I.; Yaoi, Y. Angiogenic activity of a fusion protein of the cell-binding domain of fibronectin and basic fibroblast growth factor. Cell Struct. Funct. 1994, 19, 37-47.
36. Elloumi, I.; Kobayashi, R.; Funabashi, H.; Mie, M.; Kobatake, E. Construction of epidermal growth factor fusion protein with cell adhesive activity. Biomaterials 2006, 27, 3451-3458.
37. Hannachi Imen, E.; Nakamura, M.; Mie, M.; Kobatake, E. Construction of multifunctional proteins for tissue engineering: Epidermal growth factor with collagen binding and cell adhesive activities. J. Biotechnol. 2009, 139, 19-25.
38. Van Lonkhuyzen, D.R.; Hollier, B.G.; Shooter, G.K.; Leavesley, D.I.; Upton, Z. Chimeric vitronectin:insulin-like growth factor proteins enhance cell growth and migration through co-activation of receptors. Growth Factors 2007, 25, 295-308.
39. Ogiwara, K.; Nagaoka, M.; Cho, C.S.; Akaike, T. Construction of a novel extracellular matrix using a new genetically engineered epidermal growth factor fused to IgG-Fc. Biotechnol. Lett. 2005, 27, 1633-1637.
40. Nagaoka, M.; Jiang, H.L.; Hoshiba, T.; Akaike, T.; Cho, C.S. Application of recombinant fusion proteins for tissue engineering. Ann. Biomed. Eng. 2010, 38, 683-693.
41. Nagaoka, M.; Hagiwara, Y.; Takemura, K.; Murakami, Y.; Li, J.; Duncan, S.A.; Akaike, T. Design of the artificial acellular feeder layer for the efficient propagation of mouse embryonic stem cells. J. Biol. Chem. 2008, 283, 26468-26476.
42. Azuma, K.; Nagaoka, M.; Cho, C.S.; Akaike, T. An artificial extracellular matrix created by hepatocyte growth factor fused to IgG-Fc. Biomaterials 2010, 31, 802-809.
43. Minato, A.; Ise, H.; Goto, M.; Akaike, T. Cardiac differentiation of embryonic stem cells by substrate immobilization of insulin-like growth factor binding protein 4 with elastin-like polypeptides. Biomaterials 2012, 33, 515-523.
44. Doheny, J.G.; Jervis, E.J.; Guarna, M.M.; Humphries, R.K.; Warren, R.A.; Kilburn, D.G. Cellulose as an inert matrix for presenting cytokines to target cells: Production and properties of a stem cell factor-cellulose-binding domain fusion protein. Biochem. J. 1999, 339, 429-434.
45. Segvich, S.; Kohn, D.H. Phage Display as a Strategy for Designing Organic/Inorganic Biomaterials. In Biological Interactions on Materials Surfaces-Understanding and Controlling Protein, Cell, and Tissue Responses; Puleo, D.A., Bizios, R., Eds.; Springer Sciences + Business Media: Boston, MA, USA, 2009; pp. 115-132.
46. 3 at room temperature from an aqueous salt solution at near neutral pH. J. Am. Chem. Soc. 2008, 130, 4-5.
47. 2. Anal. Chem. 2006, 78, 4872-4879.
48. Zuo, R.; Ornek, D.; Wood, K. Aluminum- and mild steel-binding peptides from phage display. Appl. Microbiol. Biotechnol. 2005, 68, 505-509.
49. Mao, C.; Flynn, C.E.; Hayhurst, A.; Sweeny, R.; Qi, J.; Georgiou, G.; Iverson, B; Belcher, A.M. Viral assembly of oriented quantum dot nanowires. Proc. Natl. Acad. Sci. USA 2003, 100, 6946-6951.
50. Lee, S.W.; Mao, C.; Flynn, C.E.; Belcher, A.M. Ordering of quantum dots using genetically engineered viruses. Science 2002, 296, 892-895.
51. Whaley, S.R.; English, D.S.; Hu, E.L.; Barbara, P.F.; Belcher, A.M. Selection of peptides with semiconductor binding specificity for directed nanocrystal assembly. Nature 2000, 405, 665-668.
52. Seker, U.O.; Wilson, B.; Dincer, S.; Kim, I.W.; Oren, E.E.; Evans, J.S.; Tamerler, C.; Sarikaya, M. Adsorption behavior of linear and cyclic genetically engineered platinum binding peptides. Langmuir 2007, 23, 7895-7900.
53. Zhang, X.; Chen, J.; Yang, P.; Yang, W. Biomimetic synthesis silver crystallite by peptide AYSSGAPPMPPF immobilized on PET film in vitro. J. Inorg. Biochem. 2005, 99, 1692-1697.
54. Naik, R.R.; Stringer, S.J.; Agarwal, G.; Jones, S.E.; Stones, M.O. Biomimetic synthesis and patterning of silver nanoparticles. Nat. Mater. 2001, 1, 169-172.
55. Kjærgaard, K.; Sørensen, J.K.; Schembri, M.A. Sequestration of zinc oxide by fimbrial designer chelators. Appl. Environ. Microbiol. 2000, 66, 10-14.
56. Dai, H.; Choe, W.-S.; Thai, C.K.; Sarikaya, M.; Traxler, B.A.; Baneyx, F.; Schwartz, D.T. Nonequilibrium synthesis and assembly of hybrid inorganic-protein nanostructures using an engineered DNA binding protein. J. Am. Chem. Soc. 2005, 127, 15637-15643.
57. Brown, S. Engineered iron oxide-adhesion mutants of the Escherichia coli phage lambda receptor. Proc. Natl Acad. Sci. USA 1992, 89, 8651-8655.
58. Sano, K.-I.; Sasaki, H.; Shiba, K. Specificity and biomineralization activities of Ti-binding peptide-1 (TBP-1). Langmuir 2005, 21, 3090-3095.
59. Segvich, S.; Biswas, S.; Becker, U.; Kohn, D. Identification of peptides with targeted adhesion to bone-like mineral via phage display and computational modeling. Cell. Tissue Org. 2009, 189, 245-251.
60. Roy, M.D.; Stanley, S.K.; Amis, E.J.; Becker, M.L. Identification of a highly specific hydroxyapatite-binding peptide using phage display. Adv. Mater. 2008, 20, 1830-1836.
61. Kashiwagi, K.; Tsuji, T.; Shiba, K. Directional BMP-2 for functionalization of titanium surfaces. Biomaterials 2009, 30, 1166-1175.
62. Merrifield, R.B. Solid phase peptide synthesis. I. The synthesis of a tetrapeptide. J. Am. Chem. Soc. 1963, 85, 2149-2154.
63. Kent, S.B.H. Total chemical synthesis of proteins. Chem. Soc. Rev. 2009, 38, 338-351.
64. Boyce, M.; Bertozzi, C.R. Bringing chemistry to life. Nat. Meth. 2011, 8, 638-642.
65. Bertozzi, C.R. A decade of bioorthogonal chemistry. Acc. Chem. Res. 2011, 44, 651-653.
66. Sletten, E.M.; Bertozzi, C.R. From mechanism to mouse: A tale of two bioorthogonal reactions. Angew. Chem. Int. Ed. 2009, 48, 6974-6998.
67. Algar, W.R.; Prasuhn, D.E.; Stewart, M.H.; Jennings, T.L.; Blanco-Canosa, J.B.; Dawson, P.E.; Medintz, I.L. The controlled display of biomolecules on nanoparticles: A challenge suited to bioorthogonal chemistry. Bioconjonct. Chem. 2011, 22, 825-858.
68. Focke, P.J.; Valiyaveetil, F.I. Studies of ion channels using expressed protein ligation. Curr. Opin. Chem. Biol. 2010, 14, 797-802.
69. Yaoung, T.S.; Schultz, P.G. Beyond the canonical 20 amino acids: Expanding the genetic lexicon. J. Biol. Chem. 2010, 285, 11039-11044.
70. Liu, C.C.; Schultz, P.G. Adding new chemistries to the genetic code. Ann. Rev. Biochem. 2010, 89, 413-444.
71. Ito, Y.; Sugimura, N.; Kwon, O.H.; Imanishi, Y. Enzyme modification by polymers with solubilities that change in response to photoirradiation in organic media. Nat. Biotechnol. 1999, 17, 73-75.
72. Tada, S.; Andou, T.; Suzuki, T.; Dohmae, N.; Kobatake, E.; Ito, Y. Genetic PEGylation. Nano Medical Engineering Laboratory, RIKEN Advanced Science Institute, Saitama, Japan. Unpublished work, 2012.
73. Veronese, F.M.; Mero, A. The impact of PEGylation on biological therapies. Biodrugs 2008, 22, 315-329.
74. Boyer, R.M.; Grover, G.N.; Maynard, H.D. Emerging synthetic approaches for protein -polymer conjugations. Chem. Commun. 2011, 47, 2212-2226.
75. Klok, H.-A. Peptide/protein-synthetic polymer conjugates: Quo vadis. Macromolecules 2009, 42, 7990-8000.
76. Joralemon, M.J.; McRae, S.; Emrick, T. PEGylated polymers for medicine: From conjugation to self-assembled systems. Chem. Commun. 2010, 46, 1377-1393.
77. Velonia, K. Protein-polymer amphiphilic chimeras: Recent advances and future challenges. Polym. Chem. 2010, 1, 944-952.
78. Sakuragi, M.; Kitajima, T.; Nagamune, T.; Ito, Y. Recombinant hBMP4 incorporated with non-canonical amino acid for binding to hydroxyapatite. Biotechnol. Lett. 2011, 33, 1885-1890.
79. Matsumoto, T.; Okazaki, M.; Nakahira, A.; Sasaki, J.; Egusa, H.; Sohmura, T. Modification of apatite materials for bone tissue engineering and drug delivery carriers. Curr. Med. Chem. 2007, 14, 2726-2733.
80. Kamitakahara, M.; Ohtsuki, C.; Miyazaki, T. Coating of bone-like apatite for development of bioactive materials for bone reconstruction. Biomed. Mater. 2007, 2, R17-R23.
81. Raj, P.A.; Johnsson, M.; Levine, M.J.; Nancollas, G.H. Salivary statherin. Dependence on sequence, charge, hydrogen bonding potency, and helical conformation for adsorption to hydroxyapatite and inhibition of mineralization. J. Biol. Chem. 1992, 267, 5968-5976.
82. Shaw, W.J.; Long, J.R.; Dindot, J.L.; Campbell, A.A.; Stayton, P.S.; Drobny, G.P. Determination of statherin N-terminal peptide conformation on hydroxyapatite crystals. J. Am. Chem. Soc. 2000, 122, 1709-1716.
83. Gilbert, M.; Shaw, W.J.; Long, J.R.; Nelson, K.; Drobny, G.P.; Giachelli, C.M.; Stayton, P.S. Chimeric peptides of statherin and osteopontin that bind hydroxyapatite and mediate cell adhesion. J. Biol. Chem. 2000, 275, 16213-16218.
84. Mazmanian, S.K.; Liu, G.; Ton-That, H.; Schneewind, O. Staphylococcus aureus sortase, an enzyme that anchors surface proteins to the cell wall. Science 1999, 285, 760-763.
85. Parthasarathy, R.; Subramanian, S.; Boder, E.T. Sortase A as a novel molecular "stapler" for sequence-specific protein conjugation. Bioconjug Chem. 2007, 18, 469-476.
86. Tanaka, T.; Yamamoto, T.; Tsukiji, S.; Nagamune, T. Site-specific protein modification on living cells catalyzed by sortase. ChemBioChem 2008, 9, 802-807.
87. Proft, T. Sortase-mediated protein ligation: An emerging biotechnology tool for protein modification and immobilisation. Biotechnol. Lett. 2010, 32, 1-10.
88. Taylor, S.M.; Jones, P.A. Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine. Cell 1979, 17, 771-779.
89. Nomura, S.; Wills, A.J.; Edwards, D.R.; Heath, J.K.; Hogan, B.L. Developmental expression of 2ar (osteopontin) and SPARC (osteonectin) RNA as revealed by in situ hybridization. J. Cell Biol. 1988, 106, 441-450.
90. Ishikawa, T.; Terai, H.; Yamamoto, T.; Harada, K.; Kitajima, T. Delivery of a growth factor fusion protein having collagen-binding activity to wound tissues. Artif. Organs 2003, 27, 147-154.
91. Sun, W.; Lin, H.; Xie, H.; Chen, B.; Zhao, W.; Han, Q.; Zhao, Y.; Xiao, Z.; Dai, J. Collagen membranes loaded with collagen-binding human PDGF-BB accelerate wound healing in a rabbit dermal ischemic ulcer model. Growth Factors 2007, 25, 309-318.
92. Ohkawara, N.; Ueda, H.; Shinozaki, S.; Kitajima, T.; Ito, Y.; Asaoka, H.; Kawakami, A.; Kaneko, E.; Shimokado, K. Hepatocyte growth factor fusion protein having collagen-binding activity (CBD-HGF) accelerates re-endothelialization and intimal hyperplasia in balloon-injured rat carotid artery. J. Atheroscler. Thromb. 2007, 14, 185-191.
93. Ota, T.; Gilbert, T.W.; Schwartzman, D.; McTiernan, C.F.; Kitajima, T.; Ito, Y.; Sawa, Y.; Badylak, S.F.; Zenati, M.A. A fusion protein of hepatocyte growth factor enhances reconstruction of myocardium in a cardiac patch derived from porcine urinary bladder matrix. J. Thorac. Cardiovasc. Surg. 2008, 136, 1309-1317.
94. Chen, B.; Lin, H.; Wang, J.; Zhao, Y.; Wang, B.; Zhao, W.; Sun, W.; Dai, J. Homogeneous osteogenesis and bone regeneration by demineralized bone matrix loading with collagen-targeting bone morphogenetic protein-2. Biomaterials 2007, 28, 1027-1035.
95. Ito, Y.; Liu, S.Q.; Imanishi, Y. Enhancement of cell growth on growth factor-immobilized polymer. Biomaterials 1991, 12, 449-453.
96. Ito, Y.; Zheng, J.; Imanishi, Y.; Yonezawa, K.; Kasuga, M. Protein-free cell culture on artificial substrata immobilized with insulin. Proc. Natl. Acad. Sci.USA 1996, 93, 3598-3560.
97. Ito, Y. Surface micropatterning to regulate cell functions. Biomaterials 1999, 2, 2333-2342.
98. Ito, Y. Covalently immobilized biosignal molecule materials for tissue engineering. Soft Matter 2008, 4, 46-56.
99. Ito, Y. Growth Factors on Biomaterial Scaffolds. In Biological Interactions on Materials Surfaces: Understanding and Controlling Protein, Cell and Tissue Responses; Puleo, D., Bizios, R., Eds.; Springer: New York, NY, USA, 2009; pp. 173-197.
100. Ito, Y. Growth Factors and Protein Modified Surfaces and Interfaces. In Comprehensive Biomaterials; Ducheyne, P., Healy, K.E., Hutmacher, D.W., Grainger, D.W., Kirkpatrick, C.J., Eds.; Elsevier: Amsterdam, the Netherlands, 2011; Volume 4, pp. 247-279.
101. Joddar, B.; Ito, Y. Biological modifications of materials surfaces with proteins for regenerative medicine. J. Mater. Chem. 2011, 21, 13737-13755.